DOCSLIB.ORG

3546 Ijsem003028

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
3546 Ijsem003028 TAXONOMIC DESCRIPTION Feng et al., Int J Syst Evol Microbiol 2018;68:3546–3550 DOI 10.1099/ijsem.0.003028 Eubacterium maltosivorans sp. nov., a novel human intestinal acetogenic and butyrogenic bacterium with a versatile metabolism Yuan Feng,1 Alfons J. M. Stams,1,2 Irene Sanchez-Andrea 1 and Willem M. de Vos1,3,* Abstract A novel anaerobic, non-spore-forming bacterium was isolated from a faecal sample of a healthy adult. The isolate, T designated strain YI , was cultured in a basal liquid medium under a gas phase of H2/CO2 supplemented with yeast extract (0.1 g lÀ1). Cells of strain YIT were short rods (0.4–0.7Â2.0–2.5 µm), appearing singly or in pairs, and stained Gram-positive. Catalase activity and gelatin hydrolysis were positive while oxidase activity, indole formation, urease activity and aesculin hydrolysis were negative. Growth was observed within a temperature range of 20–45 C (optimum, 35–37 C), and a pH range of 5.0–8.0 (optimum pH 7.0–7.5). Doubling time was 2.3 h when grown with glucose at pH 7.2 and 37 C. Besides acetogenic growth, the isolate was able to ferment a large range of monomeric sugars with acetate and butyrate as the main end products. Strain YIT did not show respiratory growth with sulfate, sulfite, thiosulfate or nitrate as electron acceptors. The T major cellular fatty acids of the isolate were C16 : 0 and C18 : 0. The genomic DNA G+C content was 47.8 mol%. Strain YI is affiliated to the genus Eubacterium, sharing highest levels of 16S rRNA gene similarity with Eubacterium limosum ATCC 8486T (97.3 %), Eubacterium callanderi DSM 3662T (97.5 %), Eubacterium aggregans DSM 12183T (94.4 %) and Eubacterium barkeri DSM 1223T (94.8 %). Considering its physiological and phylogenetic characteristics, strain YIT represents a novel species within the genus Eubacterium, for which the name Eubacterium maltosivorans sp. nov. is proposed. The type strain is YIT (=DSM 105863T=JCM 32297T). À1 The human intestinal tract is colonized by billions of com- supplemented with 5 mM Na2SO3, yeast extract (0.1 g l ; mensal micro-organisms that represent over a thousand BD BBL) and H2/CO2 (80 : 20, v/v, 1.7 atm) in the gas phase. species contributing to either health or disease. Among Throughout the enrichment, sulfite was not reduced but H2 others, intestinal microbes convert undigested carbohy- and CO2 were consumed, and acetate was produced. Subse- drates mainly into short-chain fatty acids, such as butyrate, quently, a pure culture was obtained by a combination of propionate and acetate [1–3]. As colonic fermentations are serial dilution and plating on solidified media, with 1 % generally anaerobic, redox balancing often involves the pro- noble agar (Sigma-Aldrich), under 1.7 atm of H2/CO2 duction of hydrogen, which can also be consumed by (80 : 20, v/v). methanogens, sulfur compounds respirers or homoaceto- Cell morphology, motility, Gram-staining and spore for- genic bacteria [4]. mation were studied by phase-contrast microscopy using a In the course of a study to enrich sulfidogenic bacteria from Zeiss AXIO Scope A1. Gram-staining was performed the human gut (approved by CCMO Netherlands, project according to standard procedures [7]. Survival due to ID: NL2907008109), we isolated a novel acetogenic bacterial spore formation was checked by placing the cultivation strain (YIT) sharing 97.3 % 16S rRNA gene similarity with bottle in an 80 C water bath for 20 min. Oxidase and cata- Eubacterium limosum ATCC 8486T [5]. Strain YIT was lase activities were tested as described by Florentino et al. enriched under anaerobic conditions in a basal liquid [8]. Indole and urease formation, as well as gelatin and medium prepared according to Stams et al. [6] aesculin hydrolysis were examined in duplicate by the API Author affiliations: 1Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands; 2IBB – Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal; 3RPU Immunobiology, Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland. *Correspondence: Willem M. de Vos, [email protected] Keywords: acetogens; butyrate; maltose; hydrogen; human gut microbiota. Abbreviations: ANI, average nucleotide identity; DDH, DNA–DNA hybridization. The GenBank/EMBL/DDBJ accession number for the 16S rRNA gene sequence of Eubacterium maltosivorans strain YIT is MH400075. The GenBank accession number of the assembled draft genome is GCA_002441855.1 One supplementary figure and one supplementary table are available with the online version of this article. 003028 ã 2018 IUMS Downloaded from www.microbiologyresearch.org by IP: 128.214.144.1493546 On: Thu, 15 Nov 2018 07:39:36 Feng et al., Int J Syst Evol Microbiol 2018;68:3546–3550 Table 1. Selected physiological and biochemical characteristics that differentiate strain YIT from its closest described relatives The major fatty acids are shown in bold. +, Positive; À, negative; W, weak (after 5 days less than 3 mM of substrates were consumed). Both strains stained Gram-positive, and were non-motile, non-spore-formers. Both strains were able to use H2/CO2, CO, glucose, fructose, ribose, lactate, pyru- vate, mannitol, erythritol, vanillate, cysteine and betaine, and showed weak growth on soluble starch, but were not able to use lactose, arabinose, cel- lobiose, galactose, rhamnose, melibiose, succinate, glycine, serine, glycerol or ethanol. DMA denotes dimethylacetal. Characteristic E. limosum ATCC 8486T* Strain YIT† Growth temperature 25À45 20–45 (optimum, C) (30À37) (35À37) pH range 5.0–8.0 5.0–8.0 (optimum) (7.0–7.2) (7–7.5) DNA G+C content (mol%) 47.2 47.8 Genome size (Mbp) 4.37 4.58 Sugars D-xylose w† À Maltose À† + Mannose À† + Sucrose À† + Raffinose À + Acids Formate W W Vanillate +† + Alcohol Methanol + W Cellular fatty acids (%)† Saturated straight-chain 12 : 0 0.3 0.2 14 : 0 16.8 6.3 14 : 0 DMA 1.1 0.1 16 : 0 38.6 44.5 16 : 0 aldehyde 3.8 3.0 16 : 0 DMA 9.6 9.1 18 : 0 4.6 10.5 18 : 0 aldehyde 0.6 1.5 18 : 0 DMA 1.0 3.3 20 : 0 0.3 1.1 Unsaturated straight-chain 16 : 1!5c 0.2 0.7 16 : 1!7c 1.7 1.2 16 : 1!7c DMA 0.8 0.2 18 : 1!7c 8.1 7.7 18 : 1!7c DMA 1.3 0.9 Saturated branched-chain 15 : 0 0.3 0.2 15 : 0 anteiso 0.2 À 15 : 0 iso 0.2 À 17 : 0 cyclopropane 1.4 0.8 17 : 0 cyclo DMA 0.2 0.1 19 cycloprop-11,12 6.1 7.2 19 cyclo 11,12 DMA 1.2 1.7 *Data for E. limosum ATCC 8486T were from Genthner et al. [23] (except where otherwise indicated). †Data from this study. 20A test (bioMerieux) according to the manufacturer’s To determine the temperature range and optimum, strain instructions. YIT was grown in the basal medium supplemented with Downloaded from www.microbiologyresearch.org by IP: 128.214.144.1493547 On: Thu, 15 Nov 2018 07:39:36 Feng et al., Int J Syst Evol Microbiol 2018;68:3546–3550 À1 20 mM glucose under 1.7 atm of N2/CO2 (80 : 20, v/v) gas yeast extract l ) for 2 days. Cells were harvested and analy- phase without yeast extract and incubated for up to 6 weeks sis was performed at the Identification Service of the Deut- within the temperature range from 15 to 60 C (at 5 C sche Sammlung von Mikroorganismen und Zellkulturen intervals, 37 C was tested as well) at pH 7.2. The optimum (DSMZ). pH was tested in the same medium at 37 C but bicarbonate To obtain genomic DNA, strain YIT was grown in the afore- and N /CO were omitted. Different buffer systems were 2 2 mentioned basal medium containing 20 mM glucose under employed to give different pH ranges and the gas phase con- 1.7 atm of N2/CO2 (80 : 20, v/v) for 48 h at 37 C. Biomass was tained only N . For pH higher than 7.0, 20 mM Tris was 2 harvested by centrifugation at 13 000 g for 5 min at 4 C. used; for pH 6.0–7.0, 20 mM PIPES was added; and for pH Genomic DNA was isolated by using a MasterPure device 6–4, 20 mM citrate/phosphate buffer was used. Hence, (Epicentre) and purified via a Wizard Genomic DNA Purifi- growth over the pH range from 4.0 to 8.5 was tested at 0.5 cation Kit (Promega) following the manufacturers’ instruc- unit intervals, with incubation at 37 C for up to 6 weeks. tions. Illumina MiSeq sequencing was performed at GATC Both temperature and pH tests were run in triplicate. Biotech and assembled using the Edena v3.130110 and IDBA- To explore the physiological properties of strain YIT, a vari- UD v1.1.1 assemblers and merged [11, 12]. The assembled ety of substrates including sugars, organic acids, amino draft genome had a size of 4.5 Mbp and the sequence has been acids and sugar alcohols (see Table 1) were added to the deposited at GenBank under accession number basal medium to a final concentration of 20 mM without GCA_002441855.1. The 16S rRNA gene sequence (1512 bp) yeast extract, unless mentioned otherwise. Cultures were was obtained from the draft genome and deposited at Gen- incubated under 1.7 atm of N2/CO2 (80 : 20, v/v) at 37 C Bank under accession number MG015881.
Load more

Recommended publications
  • Uneven Distribution of Cobamide Biosynthesis and Dependence in Bacteria Predicted by Comparative Genomics
    The ISME Journal (2018) 13:789–804 https://doi.org/10.1038/s41396-018-0304-9 ARTICLE Uneven distribution of cobamide biosynthesis and dependence in bacteria predicted by comparative genomics 1 1 1 1,2 3,4 3 Amanda N. Shelton ● Erica C. Seth ● Kenny C. Mok ● Andrew W. Han ● Samantha N. Jackson ● David R. Haft ● Michiko E. Taga1 Received: 7 June 2018 / Revised: 14 September 2018 / Accepted: 4 October 2018 / Published online: 14 November 2018 © The Author(s) 2018. This article is published with open access Abstract The vitamin B12 family of cofactors known as cobamides are essential for a variety of microbial metabolisms. We used comparative genomics of 11,000 bacterial species to analyze the extent and distribution of cobamide production and use across bacteria. We find that 86% of bacteria in this data set have at least one of 15 cobamide-dependent enzyme families, but only 37% are predicted to synthesize cobamides de novo. The distribution of cobamide biosynthesis and use vary at the phylum level. While 57% of Actinobacteria are predicted to biosynthesize cobamides, only 0.6% of Bacteroidetes have the complete pathway, yet 96% of species in this phylum have cobamide-dependent enzymes. The form of cobamide produced 1234567890();,: 1234567890();,: by the bacteria could be predicted for 58% of cobamide-producing species, based on the presence of signature lower ligand biosynthesis and attachment genes. Our predictions also revealed that 17% of bacteria have partial biosynthetic pathways, yet have the potential to salvage cobamide precursors. Bacteria with a partial cobamide biosynthesis pathway include those in a newly defined, experimentally verified category of bacteria lacking the first step in the biosynthesis pathway.
    [Show full text]
  • Et Al., 2015; Mandell and Green, 2011)
    Analysis of the Gut Microbiota of Japanese Alzheimer’s Disease Patients and Characterization of Their Butyrate-Producing Bacteria 2018, July NGUYEN THI THUY TIEN Graduate School of Environmental and Life Science (Doctor’s Course) OKAYAMA UNIVERSITY 0 I. GENERAL INTRODUCTION 1. Overview of Alzheimer’s disease a. Description/Definition Alzheimer’s disease (AD) is the most common type of age-related disease (aged over 65 years old), accounting for about 55 – 70% of dementia (Bertram, 2007; Bu et al., 2015; Mandell and Green, 2011). AD is characterized by progressive loss of memory and neurodegeneration of the central nervous system, leading to disorder in cognition and behavior of AD patients (Bertram, 2007; Mandell and Green, 2011). The life span of AD patients from onset may last about 10 years but can be as long as 20 years. b. Stages and symptoms of Alzheimer’s disease Stages of AD vary among individual and determination of stages that patients are suffering from is the most importance of AD treatment. The standard approach to classify AD stages relies on a mental status examination, the Mini-Mental State Examination (MMSE) (Folstein et al., 1975; Knopman). AD manifestations can be categorized into three stages with symptoms (López and DeKosky, 2008) presented in Table 1. 1 Table 1. MMSE scores and symptoms of each stage of AD (López and DeKosky, 2008) Stage by MMSE Cognitive Behavioral Neurological scores Mild Cognitive function is Apathy and heavy The neurological exam (score ≥ still in fairly good stresses may occur. cannot detect the changes. 20) condition. In this However, their mood is However, mild stage, IADL of still stable.
    [Show full text]
  • Purification and Characterization of a Novel Selenocysteine Lyase from Enterococcus Faecalis
    University of Central Florida STARS Electronic Theses and Dissertations, 2004-2019 2014 Purification and Characterization of a Novel Selenocysteine Lyase from Enterococcus faecalis Samantha Nelson University of Central Florida Part of the Biotechnology Commons, and the Molecular Biology Commons Find similar works at: https://stars.library.ucf.edu/etd University of Central Florida Libraries http://library.ucf.edu This Masters Thesis (Open Access) is brought to you for free and open access by STARS. It has been accepted for inclusion in Electronic Theses and Dissertations, 2004-2019 by an authorized administrator of STARS. For more information, please contact [email protected]. STARS Citation Nelson, Samantha, "Purification and Characterization of a Novel Selenocysteine Lyase from Enterococcus faecalis" (2014). Electronic Theses and Dissertations, 2004-2019. 4807. https://stars.library.ucf.edu/etd/4807 PURIFICATION AND CHARACTERIZATION OF A NOVEL SELENOCYSTEINE LYASE FROM ENTEROCOCCUS FAECALIS by SAMANTHA NELSON B.S. University of Central Florida, 2012 A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science in the Burnett School of Biomedical Sciences in the College of Medicine at the University of Central Florida Orlando, Florida Summer Term 2014 Major Professor: William T. Self © 2014 Samantha Nelson ii ABSTRACT A previous study identified Enterococcus faecalis as one of two bacteria known to have the selD gene and other selenium related genes without having the genes necessary to make selenocysteine or selenouridine. EF2570, a gene in the cluster, was later shown to be upregulated during biofilm formation and also responsible for a selenite- and molybdate-dependent increase in biofilm formation in vitro.
    [Show full text]
  • Reclassification of Eubacterium Hallii As Anaerobutyricum Hallii Gen. Nov., Comb
    TAXONOMIC DESCRIPTION Shetty et al., Int J Syst Evol Microbiol 2018;68:3741–3746 DOI 10.1099/ijsem.0.003041 Reclassification of Eubacterium hallii as Anaerobutyricum hallii gen. nov., comb. nov., and description of Anaerobutyricum soehngenii sp. nov., a butyrate and propionate-producing bacterium from infant faeces Sudarshan A. Shetty,1,* Simone Zuffa,1 Thi Phuong Nam Bui,1 Steven Aalvink,1 Hauke Smidt1 and Willem M. De Vos1,2,3 Abstract A bacterial strain designated L2-7T, phylogenetically related to Eubacterium hallii DSM 3353T, was previously isolated from infant faeces. The complete genome of strain L2-7T contains eight copies of the 16S rRNA gene with only 98.0– 98.5 % similarity to the 16S rRNA gene of the previously described type strain E. hallii. The next closest validly described species is Anaerostipes hadrus DSM 3319T (90.7 % 16S rRNA gene similarity). A polyphasic taxonomic approach showed strain L2-7T to be a novel species, related to type strain E. hallii DSM 3353T. The experimentally observed DNA–DNA hybridization value between strain L2-7T and E. hallii DSM 3353T was 26.25 %, close to that calculated from the genomes T (34.3 %). The G+C content of the chromosomal DNA of strain L2-7 was 38.6 mol%. The major fatty acids were C16 : 0,C16 : 1 T cis9 and a component with summed feature 10 (C18 : 1c11/t9/t6c). Strain L2-7 had higher amounts of C16 : 0 (30.6 %) compared to E. hallii DSM 3353T (19.5 %) and its membrane contained phosphatidylglycerol and phosphatidylethanolamine, which were not detected in E.
    [Show full text]
  • Dynamic Evolution of Selenocysteine Utilization in Bacteria: a Balance Between Selenoprotein Loss and Evolution of Selenocysteine from Redox Active Cysteine Residues
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Vadim Gladyshev Publications Biochemistry, Department of October 2006 Dynamic evolution of selenocysteine utilization in bacteria: a balance between selenoprotein loss and evolution of selenocysteine from redox active cysteine residues Yan Zhang University of Nebraska-Lincoln, [email protected] Hector Romero Instituto de Biología, Facultad de Ciencias, Uruguay Gustavo Salinas Instituto de Higiene, Avda A Navarro 3051, Montevideo, CP 11600, Uruguay Vadim Gladyshev University of Nebraska-Lincoln, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/biochemgladyshev Part of the Biochemistry, Biophysics, and Structural Biology Commons Zhang, Yan; Romero, Hector; Salinas, Gustavo; and Gladyshev, Vadim, "Dynamic evolution of selenocysteine utilization in bacteria: a balance between selenoprotein loss and evolution of selenocysteine from redox active cysteine residues" (2006). Vadim Gladyshev Publications. 6. https://digitalcommons.unl.edu/biochemgladyshev/6 This Article is brought to you for free and open access by the Biochemistry, Department of at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Vadim Gladyshev Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Open Access Research2006ZhangetVolume al. 7, Issue 10, Article R94 Dynamic evolution of selenocysteine utilization in bacteria: a comment balance between selenoprotein loss and evolution of selenocysteine from redox active cysteine residues Yan Zhang*, Hector Romero†, Gustavo Salinas‡ and Vadim N Gladyshev* Addresses: *Department of Biochemistry, University of Nebraska, 1901 Vine street, Lincoln, NE 68588-0664, USA. †Laboratorio de Organización y Evolución del Genoma, Laboratorio de Organización y Evolución del Genoma, Dpto de Biología Celular y Molecular, Instituto ‡ de Biología, Facultad de Ciencias, Iguá 4225, Montevideo, CP 11400, Uruguay.
    [Show full text]
  • Anaerovorax Odorimutans Gen. Nov., Sp. Nov., a Putrescine-Fermenting, Strictly Anaerobic Bacterium
    Anaerovorax odorimutans gen. nov., sp. nov., a putrescine-fermenting, strictly anaerobic bacterium Carola Matthies1, Stefan Evers2, Wolfgang Ludwig2 and Bernhard Schink3 Author for correspondence: Bernhard Schink. Tel:. j49 7531 882140 Fax: j49 7531 882966. e-mail: bernhard.schink!uni-konstanz.de 1 Lehrstuhl fu$ rO$ kologische The strictly anaerobic, Gram-positive, non-spore-forming bacterium strain $ Mikrobiologie, BITOK, NorPut1T ferments putrescine to acetate, butyrate, molecular hydrogen and Universita$ t Bayreuth, D-95440 Bayreuth, ammonia. It also utilizes 4-aminobutyrate and 4-hydroxybutyrate as growth Germany substrates. Comparative 16S rDNA sequence analysis confirmed a phylogenetic 2 Lehrstuhl fu$ r affiliation of this strain to the phylum of Gram-positive bacteria with low DNA Mikrobiologie, Technische GMC content. Together with its closest relative, ‘Clostridium aminobutyricum ’ Universita$ tMu$ nchen, (DSM 2634), and several Eubacterium species, strain NorPut1T represents a Am Hochanger 4, D-85350 Freising, Germany well-defined monophyletic group. Moderate overall 16S rRNA sequence similarities (T 91%) were found for the NorPut1T/‘Clostridium 3 Lehrstuhl fu$ r Mikrobielle O$ kologie, Fakulta$ tfu$ r aminobutyricum ’ pair and several Eubacterium species. The type species, Biologie, Universita$ t Eubacterium limosum, is not a member of the group and, together with Konstanz, Fach M 654, Eubacterium barkeri and Pseudoramibacter alactolyticus, represents a distant D-78457 Konstanz, Germany phylogentic cluster. Therefore, a new genus, Anaerovorax, is proposed as harbouring strain NorPut1T (l DSM 5092T), which is described as a new species, i.e. Anaerovorax odorimutans. Keywords: anaerobic degradation, fermentation, biogenic amines, putrescine, Eubacterium spp. Primary aliphatic amines are formed during oxygen- and a subsequent oxidation to 4-aminobutyrate, which limited decomposition of organic matter rich in pro- is further degraded via 4-hydroxybutyrate to butyrate, tein.
    [Show full text]
  • Thi Na Utaliblat in Un Minune Talk
    THI NA UTALIBLATUS010064900B2 IN UN MINUNE TALK (12 ) United States Patent ( 10 ) Patent No. : US 10 , 064 ,900 B2 Von Maltzahn et al . ( 45 ) Date of Patent: * Sep . 4 , 2018 ( 54 ) METHODS OF POPULATING A (51 ) Int. CI. GASTROINTESTINAL TRACT A61K 35 / 741 (2015 . 01 ) A61K 9 / 00 ( 2006 .01 ) (71 ) Applicant: Seres Therapeutics, Inc. , Cambridge , (Continued ) MA (US ) (52 ) U . S . CI. CPC .. A61K 35 / 741 ( 2013 .01 ) ; A61K 9 /0053 ( 72 ) Inventors : Geoffrey Von Maltzahn , Boston , MA ( 2013. 01 ); A61K 9 /48 ( 2013 . 01 ) ; (US ) ; Matthew R . Henn , Somerville , (Continued ) MA (US ) ; David N . Cook , Brooklyn , (58 ) Field of Classification Search NY (US ) ; David Arthur Berry , None Brookline, MA (US ) ; Noubar B . See application file for complete search history . Afeyan , Lexington , MA (US ) ; Brian Goodman , Boston , MA (US ) ; ( 56 ) References Cited Mary - Jane Lombardo McKenzie , Arlington , MA (US ); Marin Vulic , U . S . PATENT DOCUMENTS Boston , MA (US ) 3 ,009 ,864 A 11/ 1961 Gordon - Aldterton et al. 3 ,228 ,838 A 1 / 1966 Rinfret (73 ) Assignee : Seres Therapeutics , Inc ., Cambridge , ( Continued ) MA (US ) FOREIGN PATENT DOCUMENTS ( * ) Notice : Subject to any disclaimer , the term of this patent is extended or adjusted under 35 CN 102131928 A 7 /2011 EA 006847 B1 4 / 2006 U .S . C . 154 (b ) by 0 days. (Continued ) This patent is subject to a terminal dis claimer. OTHER PUBLICATIONS ( 21) Appl . No. : 14 / 765 , 810 Aas, J ., Gessert, C . E ., and Bakken , J. S . ( 2003) . Recurrent Clostridium difficile colitis : case series involving 18 patients treated ( 22 ) PCT Filed : Feb . 4 , 2014 with donor stool administered via a nasogastric tube .
    [Show full text]
  • Old Acetogens, New Light Steven L
    Eastern Illinois University The Keep Faculty Research & Creative Activity Biological Sciences January 2008 Old Acetogens, New Light Steven L. Daniel Eastern Illinois University, [email protected] Harold L. Drake University of Bayreuth Anita S. Gößner University of Bayreuth Follow this and additional works at: http://thekeep.eiu.edu/bio_fac Part of the Bacteriology Commons, Environmental Microbiology and Microbial Ecology Commons, and the Microbial Physiology Commons Recommended Citation Daniel, Steven L.; Drake, Harold L.; and Gößner, Anita S., "Old Acetogens, New Light" (2008). Faculty Research & Creative Activity. 114. http://thekeep.eiu.edu/bio_fac/114 This Article is brought to you for free and open access by the Biological Sciences at The Keep. It has been accepted for inclusion in Faculty Research & Creative Activity by an authorized administrator of The Keep. For more information, please contact [email protected]. Old Acetogens, New Light Harold L. Drake, Anita S. Gößner, & Steven L. Daniel Keywords: acetogenesis; acetogenic bacteria; acetyl-CoA pathway; autotrophy; bioenergetics; Clostridium aceticum; electron transport; intercycle coupling; Moorella thermoacetica; nitrate dissimilation Abstract: Acetogens utilize the acetyl-CoA Wood-Ljungdahl pathway as a terminal electron-accepting, energy-conserving, CO2-fixing process. The decades of research to resolve the enzymology of this pathway (1) preceded studies demonstrating that acetogens not only harbor a novel CO2-fixing pathway, but are also ecologically important, and (2) overshadowed the novel microbiological discoveries of acetogens and acetogenesis. The first acetogen to be isolated, Clostridium aceticum, was reported by Klaas Tammo Wieringa in 1936, but was subsequently lost. The second acetogen to be isolated, Clostridium thermoaceticum, was isolated by Francis Ephraim Fontaine and co-workers in 1942.
    [Show full text]
  • Old Acetogens, New Light Steven L
    Eastern Illinois University From the SelectedWorks of Steven L. Daniel 2008 Old Acetogens, New Light Steven L. Daniel, Eastern Illinois University Harold L. Drake, University of Bayreuth Anita S. Gößner, University of Bayreuth Available at: https://works.bepress.com/steven_daniel/3/ Old Acetogens, New Light Harold L. Drake, Anita S. Gößner, & Steven L. Daniel Keywords: acetogenesis; acetogenic bacteria; acetyl-CoA pathway; autotrophy; bioenergetics; Clostridium aceticum; electron transport; intercycle coupling; Moorella thermoacetica; nitrate dissimilation Abstract: Acetogens utilize the acetyl-CoA Wood-Ljungdahl pathway as a terminal electron-accepting, energy-conserving, CO2-fixing process. The decades of research to resolve the enzymology of this pathway (1) preceded studies demonstrating that acetogens not only harbor a novel CO2-fixing pathway, but are also ecologically important, and (2) overshadowed the novel microbiological discoveries of acetogens and acetogenesis. The first acetogen to be isolated, Clostridium aceticum, was reported by Klaas Tammo Wieringa in 1936, but was subsequently lost. The second acetogen to be isolated, Clostridium thermoaceticum, was isolated by Francis Ephraim Fontaine and co-workers in 1942. C. thermoaceticum became the most extensively studied acetogen and was used to resolve the enzymology of the acetyl- CoA pathway in the laboratories of Harland Goff Wood and Lars Gerhard Ljungdahl. Although acetogenesis initially intrigued few scientists, this novel process fostered several scientific milestones, including the first 14C-tracer studies in biology and the discovery that tungsten is a biologically active metal. The acetyl-CoA pathway is now recognized as a fundamental component of the global carbon cycle and essential to the metabolic potentials of many different prokaryotes.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,799,545 B2 Burgard Et Al
    US007799545B2 (12) United States Patent (10) Patent No.: US 7,799,545 B2 Burgard et al. (45) Date of Patent: Sep. 21, 2010 (54) MICROORGANISMS FOR THE 4,082,788 A 4/1978 Mims PRODUCTION OF ADPCACID AND OTHER 4,190.495 A 2/1980 Curtiss COMPOUNDS 4,301,077 A 1 1/1981 Pesa et al. 4,624,920 A 11/1986 Inoue et al. (75)75 Inventors: Anthony P. Burgard, Bellefonte, PA 4,871,6674,652,685 A 10/19893, 1987 ImadaCawse etet al.al. (US); Priti Pharkya, San Diego, CA (US); Robin E. Osterhout, San Diego, (Continued) CA (US) FOREIGN PATENT DOCUMENTS (73) Assignee: Genomatica, Inc., San Diego, CA (US) CN 1358 841 T 2002 *) NotOt1Ce: Subjubject to anyy d1Sclaimer,disclai theh term off thithis (Continued)ontinue patent is extended or adjusted under 35 OTHER PUBLICATIONS U.S.C. 154(b) by 47 days. Alhapel et al., “Molecular and functional analysis of nicotinate (21) Appl. No.: 12/413,355 catabolism in Eubacterium barkeri,’ Proc. Natl. Acad. Sci. USA 103(33):12341-12346 (2006). (22) Filed: Mar. 27, 2009 (Continued) (65) Prior Publication Data Primary Examiner Nashaat T Nashed US 2009/0305364 A1 Dec. 10, 2009 (74) Attorney, Agent, or Firm McDermott Will & Emery • ws LLP Related U.S. Application Data (57) ABSTRACT (60) Provisional application No. 61/040,059, filed on Mar. 27, 2008. The invention provides a non-naturally occurring microbial organism having an adipate, 6-aminocaproic acid or capro (51) Int. Cl. lactam pathway. The microbial organism contains at least one CI2P 7/40 (2006.01) exogenous nucleic acid encoding an enzyme in the respective CI2N L/20 (2006.01) adipate, 6-aminocaproic acid or caprolactam pathway.
    [Show full text]
  • Determining and Comparing Protein Function in Bacterial Genome Sequences
    Downloaded from orbit.dtu.dk on: Oct 04, 2021 Determining and comparing protein function in Bacterial genome sequences Vesth, Tammi Camilla Publication date: 2014 Document Version Peer reviewed version Link back to DTU Orbit Citation (APA): Vesth, T. C. (2014). Determining and comparing protein function in Bacterial genome sequences. Technical University of Denmark. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. D e t e r m i n i n g a n d c o m p a r i n g p r o t e i n f u n c t i o n i n B a c t e r i a l g e n o m e s e q u e n c e s T a m m i C a m i l l a V e s t h J a n u a r y 2 9 , 2 0 1 4 Information is not knowledge - Albert Einstein Contents Preface .
    [Show full text]
  • Eubacterium Maltosivorans Sp. Nov., a Novel Human Intestinal Acetogenic and Butyrogenic Bacterium with a Versatile Metabolism
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Helsingin yliopiston digitaalinen arkisto TAXONOMIC DESCRIPTION Feng et al., Int J Syst Evol Microbiol 2018;68:3546–3550 DOI 10.1099/ijsem.0.003028 Eubacterium maltosivorans sp. nov., a novel human intestinal acetogenic and butyrogenic bacterium with a versatile metabolism Yuan Feng,1 Alfons J. M. Stams,1,2 Irene Sanchez-Andrea 1 and Willem M. de Vos1,3,* Abstract A novel anaerobic, non-spore-forming bacterium was isolated from a faecal sample of a healthy adult. The isolate, T designated strain YI , was cultured in a basal liquid medium under a gas phase of H2/CO2 supplemented with yeast extract (0.1 g lÀ1). Cells of strain YIT were short rods (0.4–0.7Â2.0–2.5 µm), appearing singly or in pairs, and stained Gram-positive. Catalase activity and gelatin hydrolysis were positive while oxidase activity, indole formation, urease activity and aesculin hydrolysis were negative. Growth was observed within a temperature range of 20–45 C (optimum, 35–37 C), and a pH range of 5.0–8.0 (optimum pH 7.0–7.5). Doubling time was 2.3 h when grown with glucose at pH 7.2 and 37 C. Besides acetogenic growth, the isolate was able to ferment a large range of monomeric sugars with acetate and butyrate as the main end products. Strain YIT did not show respiratory growth with sulfate, sulfite, thiosulfate or nitrate as electron acceptors. The T major cellular fatty acids of the isolate were C16 : 0 and C18 : 0.
    [Show full text]